HHTM

SOMERSET, NJ October 24 – Oticon, Inc. again joins Homes For Our Troops (HFOT) to support the national non-profit organization’s work of building and donating specially adapted custom homes nationwide to severely injured post-9/11 Veterans, enabling them to rebuild their lives. These Veterans have sustained multiple amputations, paralysis, blindness or traumatic brain injury. Oticon has supported the Homes For Our

MONTPELLIER, FRANCE – Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage  biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the initiation of a Proof of Concept (PoC) clinical trial of SENS-401 (Arazasetron) in patients with Cisplatin-Induced Ototoxicity (CIO) has been approved by regulatory authorities

VALENCIA, CALIFORNIA — Cochlear implant maker, Advanced Bionics, announced the launch of an emotional patient ‘connection’ campaign. Following the successful launch of their Naída CI Marvel for adults and Sky CI Marvel for children in 2020, this new campaign is designed to “highlight the human truth that our lives are enriched and fulfilled by deep and meaningful connections with those

Hearing Health & Technology Matters today announces the winners of its third annual Hearing Technology Innovator Awards™. Through the annual awards program, HHTM honors technological innovation and achievement in the hearing industry. This year’s expanded program was the most competitive yet and received entries from some of the most innovative companies from around the world. “With the culmination of this

In this week’s special episode, Dave Kemp catches up with Wade Colburn and Dr. Marlan Hansen of iotaMotion, a medtech startup spun out of the University of Iowa. The company was recently named ‘Innovator of the Year’ in the 2022 Hearing Technology Innovator Awards for its iotaSOFT Insertion System – a robotic-assisted insertion technology intended to aid surgeons in the

INDIANAPOLIS and BOSTON — Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a precision genetic medicine company that is developing a portfolio of first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss. “We are honored to work with the talented team at Akouos who are breaking new ground

FORT WORTH, TEXAS — Lucid Hearing, LLC, a Fort Worth-based provider of advanced hearing technology and audio solutions, is offering its over-the-counter (OTC) hearing aids to consumers in more than 450 Sam’s Club locations nationwide starting today. An August ruling finalized by the Food and Drug Administration (FDA) opens up a market for OTC hearing devices, a long-awaited industry event for which Lucid Hearing

LOWELL, MASSACHUSSETTS – GN today announces that the Jabra Enhance Plus hearing enhancement earbuds are now available over the counter (OTC). This follows the US Food & Drug Administration’s (FDA) new regulation establishing an OTC hearing aid category, which is now in effect. As an OTC product, “the Jabra Enhance Plus will help millions of Americans with unaddressed hearing  loss take

SEATTLE, WASHINGTON – SafKan Health and ReSound are pleased to announce they have entered into a partnership to make the FDA-cleared OtoSet® Ear Cleaning System available through ReSound Accelerate, a customer engagement program with more than 1,000 active members. Beginning in October of this year, the OtoSet Ear Cleaning System will be available on the ReSound Accelerate MarketPlace, allowing members

BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 1/2 clinical trial in pediatric patients of DB-OTO, its lead